Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Anticoagulation after Ablation for Atrial Fibrillation — Navigating the OCEAN of Possibilities January 22, 2026Under current guidelines, discontinuation of oral anticoagulant therapy is not considered to be a benefit that can be routinely offered to patients who have undergone ablation for atrial fibrillation. Even after apparently successful ablation, continuation of anticoagulant therapy is recommended when indicated by the CHA2DS2 -VASc score...
- Physiologic Pacing in Heart Failure January 22, 2026This review summarizes cardiac physiologic pacing for heart failure, highlighting benefits of biventricular pacing and emerging evidence for His-bundle and left bundle-branch pacing to improve function and outcomes.
- Not Otherwise Specified — Season 3: The Forever Crisis of Primary Care: Autonomy vs. Equity — NOS Episode 3.9 January 22, 2026With increasing numbers of PCPs leaving traditional practice for concierge medicine or direct primary care, NOS host Lisa Rosenbaum and her guests explore the promise and perils.
- Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation January 22, 2026In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy.
- Managing Asymptomatic Carotid Stenosis January 15, 2026The management of carotid-artery stenosis that has not caused recent symptoms — asymptomatic carotid stenosis — has been controversial. Clinical trials that began more than 30 years ago showed a small benefit of carotid endarterectomy as compared with medical treatment, but improvements in medical prevention of stroke call into question...
- Anticoagulation after Ablation for Atrial Fibrillation — Navigating the OCEAN of Possibilities January 22, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
